Difference between revisions of "Levofloxacin (Levaquin)"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
||
| Line 11: | Line 11: | ||
[[Category:Fluoroquinolone]] | [[Category:Fluoroquinolone]] | ||
| − | [[Category: | + | [[Category:FDA approved in 1996]] |
Revision as of 19:24, 30 July 2018
A fluoroquinolone antibiotic often used as prophylaxis during anticipated neutropenic nadirs. No known antineoplastic properties.
Also known as
- Brand name: Levaquin
References
- Bucaneve G, Micozzi A, Menichetti F, Martino P, Dionisi MS, Martinelli G, Allione B, D'Antonio D, Buelli M, Nosari AM, Cilloni D, Zuffa E, Cantaffa R, Specchia G, Amadori S, Fabbiano F, Deliliers GL, Lauria F, Foà R, Del Favero A; Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Infection Program. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med. 2005 Sep 8;353(10):977-87. link to original article PubMed